(Q44106077)

English

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

scientific article published in August 2002

Statements

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). (English)
Nadia Harbeck
Ronald E Kates
Maxime P Look
Marion E Meijer-Van Gelder
Jan G M Klijn
Achim Krüger
Marion Kiechle
Fritz Jänicke
Manfred Schmitt
John A Foekens
1 August 2002
4617-4622

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit